PTTG1 and adrenal cortex carcinoma: Patients with high expression of PTTG1 were associated with poor overall survival (OS) in ACC, KIRC, KIRP, lower grade glioma (LGG), LIHC, LUAD, mesothelioma (MESO), PAAD, THCA, and uveal melanoma (UVM) (Figure 5A, all p < 0.05).